(in thousands)
|
||||||||
Year Ended
|
Three Months
Ended
|
|||||||
December 31,
|
December 31,
|
|||||||
2008
|
2008
|
|||||||
GAAP
Net loss
|
$ | (2,859 | ) | $ | (1,927 | ) | ||
Adjustments:
|
||||||||
Cost
of Sales – non-cash employee compensation
|
856 | 548 | ||||||
Operating
Expenses – non-cash employee compensation
|
5,690 | 1,498 | ||||||
Adjusted
Net Income
|
$ | 3,687 | $ | 119 |
December
31
|
||||||||
2008
|
2007
|
|||||||
ASSETS
|
||||||||
Current
Assets
|
||||||||
Cash
and cash equivalents
|
$ | 5,580,244 | $ | 9,907,691 | ||||
Restricted
cash
|
650,000 | 0 | ||||||
Accounts
receivable - project revenue and reimbursable project
costs
|
5,357,804 | 0 | ||||||
Prepaid
expenses & other current assets
|
394,315 | 204,035 | ||||||
Deferred
project costs
|
0 | 371,631 | ||||||
Total
Current Assets
|
11,982,363 | 10,483,357 | ||||||
Property
Plant and Equipment -net
|
108,121 | 30,676 | ||||||
Other
Assets
|
||||||||
Patent
costs - net
|
217,875 | 217,875 | ||||||
Security
deposits
|
138,418 | 2,049 | ||||||
Total
Other Assets
|
356,293 | 219,924 | ||||||
Total
Assets
|
$ | 12,446,777 | $ | 10,733,957 | ||||
LIABILITIES
AND STOCKHOLDERS EQUITY
|
||||||||
Current
Liabilities
|
||||||||
Accounts
payable and accrued liabilities
|
$ | 5,138,979 | $ | 2,122,649 | ||||
Current
portion long term debt
|
0 | 4,651 | ||||||
Customer
deposit
|
0 | 1,206,875 | ||||||
Deferred
revenue
|
0 | 3,793,125 | ||||||
Total
Current Liabilities
|
5,138,979 | 7,127,300 | ||||||
Notes
Payable - long term
|
0 | 5,782 | ||||||
Total
Liabilities
|
5,138,979 | 7,133,082 | ||||||
Commitments
and contingencies
|
||||||||
Stockholders'
Equity
|
||||||||
Preferred
stock, $0.001 par value, 50,000,000 authorized shares, no shares issued
and outstanding
|
- | - | ||||||
Common
stock, $0.001par value, 500,000,000 authorized, 301,493,084 shares issued
and outstanding at December 31, 2008 and 299,014,182 shares
issued and outstanding at December 31, 2007
|
301,493 | 299,014 | ||||||
Additional
paid in capital - stock and stock equivalents
|
48,607,451 | 41,791,735 | ||||||
Deficit
|
(41,489,974 | ) | (38,630,572 | ) | ||||
Common
stock reserved for issuance, 484,055 shares and 2,000,000 shares at
December 31, 2008 and 2007, respectively
|
114,787 | 590,000 | ||||||
Accumulated
other comprehensive income
|
0 | 30,143 | ||||||
Deferred
stock compensation
|
(225,959 | ) | (479,445 | ) | ||||
Total
Stockholders' Equity
|
7,307,798 | 3,600,875 | ||||||
Total
Liabilities and Stockholders' Equity
|
$ | 12,446,777 | $ | 10,733,957 |
For the Years Ended
|
||||||||
December 31,
|
||||||||
2008
|
2007
|
|||||||
Revenue:
|
||||||||
Consulting
revenue
|
$ | 22,219,905 | $ | 0 | ||||
Total
Revenue
|
22,219,905 | 0 | ||||||
Cost
of Consulting Services Provided
|
11,088,723 | 0 | ||||||
Gross
Margin
|
11,131,182 | 0 | ||||||
Operating
Expenses
|
||||||||
General
and administrative
|
6,958,165 | 6,259,317 | ||||||
Research
and development expenses
|
1,565,594 | 756,755 | ||||||
Stock-based
compensation
|
5,649,835 | 4,745,098 | ||||||
Total
Operating Expenses
|
14,173,594 | 11,761,170 | ||||||
Operating
loss
|
(3,042,412 | ) | (11,761,170 | ) | ||||
Other
Income and (Expenses)
|
||||||||
Interest
income
|
162,893 | 367,187 | ||||||
Other
income and expenses
|
30,143 | (58,600 | ) | |||||
Total
Other Income and Expenses
|
193,036 | 308,587 | ||||||
Net
loss before income taxes
|
(2,849,376 | ) | (11,452,583 | ) | ||||
Income
taxes
|
10,026 | 0 | ||||||
Net loss
|
(2,859,402 | ) | (11,452,583 | ) | ||||
Other
Comprehensive Income (Loss)
|
||||||||
Unrealized
gain on marketable securities
|
0 | 11,282 | ||||||
Total
Comprehensive Loss
|
$ | (2,859,402 | ) | $ | (11,441,301 | ) | ||
Net
Loss Per Common Share, Basic and diluted
|
$ | (0.01 | ) | $ | (0.04 | ) | ||
Weighted
Average Number of shares outstanding for the period used to compute per
share data
|
300,070,925 | 296,666,502 |
For the Years Ended
|
||||||||
December 31,
|
||||||||
2008
|
2007
|
|||||||
Operating
Activities:
|
||||||||
Net
Loss
|
$ | (2,859,402 | ) | $ | (11,452,583 | ) | ||
Adjustments
to reconcile net loss from operations to net cash used in operating
activities:
|
||||||||
Stock
based compensation
|
6,546,493 | 4,978,981 | ||||||
Depreciation
and amortization
|
24,668 | 8,582 | ||||||
Realized
gain on sale of securities
|
(30,143 | ) | 0 | |||||
Settlement
Expense
|
0 | 58,601 | ||||||
Changes
in non-cash operating working capital items:
|
||||||||
Accounts
receivable - fees and reimburseable project costs
|
(5,357,804 | ) | 0 | |||||
Prepaid
expenses and other current assets
|
(190,280 | ) | 321,966 | |||||
Security
deposits
|
(136,369 | ) | 0 | |||||
Accounts
payable, accrued liabilities and other current liabilities
|
1,809,455 | 1,293,951 | ||||||
Deferred
revenue
|
(3,793,125 | ) | 3,793,125 | |||||
Deferred
project costs - net
|
371,631 | 0 | ||||||
Net
Cash Used In Operating Activities
|
(3,614,876 | ) | (997,377 | ) | ||||
Investing
Activities:
|
||||||||
Purchase
of office equipment
|
(102,113 | ) | (17,968 | ) | ||||
Net
Cash Used In Investing Activities
|
(102,113 | ) | (17,968 | ) | ||||
Financing
Activities:
|
||||||||
Proceeds
from issue of common shares
|
49,975 | 0 | ||||||
Payments
on notes payable and other
|
(10,433 | ) | (4,739 | ) | ||||
Restricted
cash
|
(650,000 | ) | 0 | |||||
Net
Cash Used In Financing Activities
|
(610,458 | ) | (4,739 | ) | ||||
Net
Decrease In Cash and Cash Equivalents
|
(4,327,447 | ) | (1,020,084 | ) | ||||
Cash
and Cash Equivalents, Beginning of Year
|
9,907,691 | 10,927,775 | ||||||
Cash
and Cash Equivalents, End of Year
|
$ | 5,580,244 | $ | 9,907,691 | ||||
Supplemental
Disclosure of Cash Flow Information
|
||||||||
Cash
paid during the year:
|
||||||||
Interest
paid
|
$ | 0 | $ | 876 | ||||
Income
taxes paid
|
$ | 10,026 | $ | 0 | ||||
Non-cash
transactions
|
||||||||
Conversion
of liabilities to equity
|
$ | 0 | $ | 278,441 |